Attila Tóth

5.8k total citations
151 papers, 4.4k citations indexed

About

Attila Tóth is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Attila Tóth has authored 151 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Cardiology and Cardiovascular Medicine, 44 papers in Molecular Biology and 37 papers in Physiology. Recurrent topics in Attila Tóth's work include Ion Channels and Receptors (27 papers), Cardiomyopathy and Myosin Studies (20 papers) and Cardiac electrophysiology and arrhythmias (14 papers). Attila Tóth is often cited by papers focused on Ion Channels and Receptors (27 papers), Cardiomyopathy and Myosin Studies (20 papers) and Cardiac electrophysiology and arrhythmias (14 papers). Attila Tóth collaborates with scholars based in Hungary, United States and South Korea. Attila Tóth's co-authors include Peter M. Blumberg, Zoltán Papp, István Édes, Noémi Kedei, Zsolt Bagi, Judit Boczán, Erzsébet Lizanecz, Mihály Braun, Katherine J. Willis and Pál Sümegi and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Attila Tóth

148 papers receiving 4.3k citations

Peers

Countries citing papers authored by Attila Tóth

Since Specialization

Citations

This map shows the geographic impact of Attila Tóth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Attila Tóth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Attila Tóth more than expected).

Fields of papers citing papers by Attila Tóth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Attila Tóth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Attila Tóth. The network helps show where Attila Tóth may publish in the future.

Co-authorship network of co-authors of Attila Tóth

This figure shows the co-authorship network connecting the top 25 collaborators of Attila Tóth. A scholar is included among the top collaborators of Attila Tóth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Attila Tóth. Attila Tóth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Syndrome and Biotherapeutic Activity of Dairy (Cow and Buffalo) Milk Proteins and Peptides: Fast Food-Induced Obesity Perspective—A Narrative Review 2024 ·Biomolecules ·(unknown), (unknown), (unknown), László Friedrich, Zoltán Lakner, András Kőris, Attila Tóth, (unknown)	9
2	Get reliable laboratory findings – how to recognize the deceptive effects of angiotensin-converting enzyme inhibitor therapy in the laboratory diagnostics of sarcoidosis? 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Attila Tóth, Zoltán Papp, Miklós Fagyas	1
3	ACE Phenotyping in Human Blood and Tissues: Revelation of ACE Outliers and Sex Differences in ACE Sialylation 2024 ·Biomedicines ·(unknown), Pavel A. Petukhov, (unknown), Steven M. Dudek, Attila Tóth, Miklós Fagyas, Sergei M. Danilov	1
4	Omecamtiv Mecarbil Augments Cardiomyocyte Contractile Activity Both at Resting and Systolic Ca2+ Levels 2023 ·ESC Heart Failure ·(unknown), Attila Tóth, (unknown), Balázs Horváth, Norbert Szentandrássy, Péter P. Nánási, Zoltán Csanádi, István Édes, Zoltán Papp, Attila Borbély	6
5	Accelerated ageing and coronary microvascular dysfunction in chronic heart failure in Tgαq44 mice 2023 ·GeroScience* ·(unknown), Justyna Totoń‐Żurańska, Grzegorz Kwiatkowski, Agnieszka Jasztal, Tamás Csípő, Kamil Kuś, (unknown), (unknown), Paweł Wołkow, Attila Tóth, Stefan Chłopicki	7
6	Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity 2023 ·Biomedicines ·(unknown), Pavel A. Petukhov, Miklós Fagyas, (unknown), (unknown), (unknown), А А Камалов, Attila Tóth, Steven M. Dudek, Sergei M. Danilov	5
7	Enalapril Is Superior to Lisinopril in Improving Endothelial Function without a Difference in Blood–Pressure–Lowering Effects in Newly Diagnosed Hypertensives 2023 ·Biomedicines ·Attila Nagy, (unknown), Judit Boczán, Sándor Sipka, Attila Szabó, (unknown), (unknown), Miklós Fagyas, Zoltán Papp, László Csiba, Attila Tóth	5
8	Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats 2023 ·Frontiers in Cardiovascular Medicine ·Saltanat Zhazykbayeva, (unknown), Melissa Herwig, Heidi Budde, Árṕad Kov́acs, Hans Georg Mannherz, Ibrahim El‐Battrawy, Attila Tóth, Wolfgang E. Schmidt, Andreas Mügge, Nazha Hamdani	6
9	A Central Role for TRPM4 in Ca2+-Signal Amplification and Vasoconstriction 2022 ·International Journal of Molecular Sciences ·Tamás Csípő, Ágnes Czikora, Gábor Áron Fülöp, (unknown), Ibolya Rutkai, (unknown), Róbert Pórszász, (unknown), Kata Bölcskei, Zsuzsanna Helyes, Erika Pintér, Zoltán Papp, Zoltán Ungvári, Attila Tóth	10
10	Alterations in ACE and ACE2 Activities and Cardiomyocyte Signaling Underlie Improved Myocardial Function in a Rat Model of Repeated Remote Ischemic Conditioning 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), (unknown), (unknown), Miklós Fagyas, Petra Lujza Szabó, Dietmar Abraham, Attila Tóth, Bruno K. Podesser, Attila Kiss, Zoltán Papp	1
11	Nicotinic‐acid derivative BGP‐15 improves diastolic function in a rabbit model of atherosclerotic cardiomyopathy 2021 ·British Journal of Pharmacology ·Dániel Priksz, (unknown), Árṕad Kov́acs, Melissa Herwig, Mariann Bombicz, Balázs Varga, (unknown), (unknown), Anikó Pósa, Rita Kiss, Rudolf Gesztelyi, (unknown), (unknown), (unknown), Zoltán Papp, Attila Tóth, Nazha Hamdani, Zoltán Szilvássy, Béla Juhász	7
12	Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients 2021 ·International Journal of Infectious Diseases ·Miklós Fagyas, Zsolt Fejes, (unknown), Zsuzsanna Nagy, (unknown), (unknown), (unknown), (unknown), Gabriella Bekő, Attila Nagy, György Kerekes, (unknown), Zoltán Papp, Attila Tóth, János Kappelmayer, Béla Nagy	69
13	Bioactive Peptides from Liquid Milk Protein Concentrate by Sequential Tryptic and Microbial Hydrolysis 2021 ·Processes ·(unknown), (unknown), (unknown), (unknown), Klára Pásztor‐Huszár, Attila Tóth, Krisztina Takács, (unknown), Gabriella Kiskó, Zoltán Kovács, András Kőris, Gyula Vatai	7
14	A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient 2020 ·International Journal of Infectious Diseases ·Béla Nagy, Zsolt Fejes, (unknown), (unknown), István Várkonyi, Éva Ajzner, János Kappelmayer, Zoltán Papp, Attila Tóth, Miklós Fagyas	53
15	The Drug Candidate BGP-15 Delays the Onset of Diastolic Dysfunction in the Goto-Kakizaki Rat Model of Diabetic Cardiomyopathy 2019 ·Molecules ·Mariann Bombicz, Dániel Priksz, Rudolf Gesztelyi, Rita Kiss, N Hollos, Balázs Varga, József Németh, Attila Tóth, Zoltán Papp, Zoltán Szilvássy, Béla Juhász	15
16	Optimized angiotensin-converting enzyme activity assay for the accurate diagnosis of sarcoidosis 2018 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Attila Enyedi, István Takács, Tamás Végh, (unknown), (unknown), (unknown), József Balla, György Balla, István Édes, János Kappelmayer, Attila Tóth, Zoltán Papp, Miklós Fagyas	13
17	Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease 2018 ·International Journal of Molecular Sciences ·Dániel Priksz, Mariann Bombicz, Balázs R. Varga, (unknown), Rudolf Gesztelyi, József Balla, Attila Tóth, Zoltán Papp, Zoltán Szilvássy, Béla Juhász	17
18	ORM-3819 promotes cardiac contractility through Ca2+ sensitization in combination with selective PDE III inhibition, a novel approach to inotropy 2016 ·European Journal of Pharmacology ·László Nagy, Piero Pollesello, Heimo Haikala, Ágnes Végh, Tia Sorsa, Jouko Levijoki, (unknown), István Édes, Attila Tóth, Zoltán Papp, Julius Gy. Papp	4
19	Heteroduplex analysis using flow cytometric microbead assays to detect deletions, insertions, and single‐strand lesions 2008 ·Cytometry Part A ·(unknown), (unknown), (unknown), Erzsébet Lizanecz, Lóránt Székvölgyi, Ferenc Fazakas, Zsolt Bacsó, Attila Tóth, (unknown), Z. Seres, Gábor Szabó	2
20	Structure–activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding 2004 ·Bioorganic & Medicinal Chemistry ·Jeewoo Lee, Su Yeon Kim, Soyoung Park, (unknown), (unknown), Myungshim Kang, Jiyoun Lee, Sang-Uk Kang, Hyun‐Kyung Choi, (unknown), (unknown), Tamás Szabó, Richard Tran, Larry V. Pearce, Attila Tóth, Peter M. Blumberg	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact